All Phenotypes Tg(Wnt1)1Hev MGI Mouse

About Help FAQ

Phenotypes associated with this allele

Allele Symbol
Allele Name
Allele ID

Tg(Wnt1)1Hev
transgene insertion 1, Harold E Varmus
MGI:1890080

Summary

14 genotypes

Jump to	Allelic Composition	Genetic Background	Genotype ID
cx1	Mtdh^Gt(XB780)Byg/Mtdh⁺ Tg(Wnt1)1Hev/0	FVB.Cg-Mtdh^Gt(XB780)Byg Tg(Wnt1)1Hev	MGI:5649042
cx2	Mtdh^Gt(XB780)Byg/Mtdh^Gt(XB780)Byg Tg(Wnt1)1Hev/0	FVB.Cg-Mtdh^Gt(XB780)Byg Tg(Wnt1)1Hev	MGI:5649041
cx3	Esr1^tm1Ksk/Esr1^tm1Ksk Tg(Wnt1)1Hev/0	involves: 129P2/OlaHsd * C57BL/6 * SJL	MGI:4437739
cx4	Id2^tm1Yyk/Id2^tm1Yyk Tg(Wnt1)1Hev/0	involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB * SJL	MGI:3773758
cx5	Id2^tm1Yyk/Id2⁺ Tg(Wnt1)1Hev/0	involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB * SJL	MGI:3773817
cx6	Pten^tm1Rps/Pten⁺ Tg(Wnt1)1Hev/0	involves: 129S1/Sv * C57BL/6 * FVB/N * SJL	MGI:5442747
cx7	Sdc1^tm1Cma/Sdc1⁺ Tg(Wnt1)1Hev/0	involves: 129S4/SvJae * C57BL/6 * SJL	MGI:3521902
cx8	Sdc1^tm1Cma/Sdc1^tm1Cma Tg(Wnt1)1Hev/0	involves: 129S4/SvJae * C57BL/6 * SJL	MGI:3521901
cx9	Muc1^tm1Gend/Muc1^tm1Gend Tg(Wnt1)1Hev/?	involves: FVB	MGI:3574843
cx10	Chek1^tm1Sje/Chek1⁺ Tg(Wnt1)1Hev/0	Not Specified	MGI:3588947
tg11	Tg(Wnt1)1Hev/0	either: FVB/N or (involves: C57BL/6 * SJL)	MGI:2174885
tg12	Tg(Wnt1)1Hev/0	involves: 129P2/OlaHsd * C57BL/6 * SJL	MGI:4437740
tg13	Tg(Wnt1)1Hev/0	involves: C57BL/6 * FVB * SJL	MGI:3773757
tg14	Tg(Wnt1)1Hev/0	involves: C57BL/6 * SJL	MGI:4819121

Allelic Composition	Mtdh^Gt(XB780)Byg/Mtdh⁺ Tg(Wnt1)1Hev/0
Genetic Background	FVB.Cg-Mtdh^Gt(XB780)Byg Tg(Wnt1)1Hev

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mtdh^Gt(XB780)Byg mutation (0 available); any Mtdh mutation (33 available)
Tg(Wnt1)1Hev mutation (2 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

decreased mammary gland tumor incidence ( J:214244 )

• no tumors are detected in 35% of mice at 300 days of age unlike in transgenic mice wild-type for Mtdh

• the number of tumors in mice with tumors is also reduced compared to transgenic mice wild-type for Mtdh

increased tumor latency ( J:214244 )

• no tumors are detected in 35% of mice at 300 days of age unlike in transgenic mice wild-type for Mtdh

endocrine/exocrine glands

decreased mammary gland tumor incidence ( J:214244 )

• no tumors are detected in 35% of mice at 300 days of age unlike in transgenic mice wild-type for Mtdh

• the number of tumors in mice with tumors is also reduced compared to transgenic mice wild-type for Mtdh

integument

decreased mammary gland tumor incidence ( J:214244 )

• no tumors are detected in 35% of mice at 300 days of age unlike in transgenic mice wild-type for Mtdh

• the number of tumors in mice with tumors is also reduced compared to transgenic mice wild-type for Mtdh

Allelic Composition	Mtdh^Gt(XB780)Byg/Mtdh^Gt(XB780)Byg Tg(Wnt1)1Hev/0
Genetic Background	FVB.Cg-Mtdh^Gt(XB780)Byg Tg(Wnt1)1Hev

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mtdh^Gt(XB780)Byg mutation (0 available); any Mtdh mutation (33 available)
Tg(Wnt1)1Hev mutation (2 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

decreased mammary gland tumor incidence ( J:214244 )

• no tumors are detected in 62% of mice at 300 days of age unlike in transgenic mice wild-type for Mtdh

• the number of tumors in mice with tumors is also reduced compared to transgenic mice wild-type for Mtdh

increased tumor latency ( J:214244 )

• no tumors are detected in 62% of mice at 300 days of age unlike in transgenic mice wild-type for Mtdh

integument

decreased mammary gland tumor incidence ( J:214244 )

• no tumors are detected in 62% of mice at 300 days of age unlike in transgenic mice wild-type for Mtdh

• the number of tumors in mice with tumors is also reduced compared to transgenic mice wild-type for Mtdh

mammary gland hyperplasia ( J:214244 )

• display fewer and smaller hyperplastic foci at 4 weeks of age compared to transgenic mice wild-type for Mtdh

endocrine/exocrine glands

decreased mammary gland tumor incidence ( J:214244 )

• no tumors are detected in 62% of mice at 300 days of age unlike in transgenic mice wild-type for Mtdh

• the number of tumors in mice with tumors is also reduced compared to transgenic mice wild-type for Mtdh

mammary gland hyperplasia ( J:214244 )

• display fewer and smaller hyperplastic foci at 4 weeks of age compared to transgenic mice wild-type for Mtdh

Allelic Composition	Esr1^tm1Ksk/Esr1^tm1Ksk Tg(Wnt1)1Hev/0
Genetic Background	involves: 129P2/OlaHsd * C57BL/6 * SJL

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Esr1^tm1Ksk mutation (2 available); any Esr1 mutation (68 available)
Tg(Wnt1)1Hev mutation (2 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased mammary adenocarcinoma incidence ( J:54215 )

• both sexes develop lobuloalveolar adenocarcinomas

increased tumor latency ( J:54215 )

• compared to transgenic mice wild-type for Esr1

endocrine/exocrine glands

abnormal mammary gland development ( J:54215 )

• virgin females display underdeveloped glands at 10 weeks of age with a hyperplastic rudimentary ductal network that lacks terminal end buds

mammary gland duct hyperplasia ( J:54215 )

• in the interior of the gland in virgin females

mammary gland alveolar hyperplasia ( J:54215 )

• in virgin females, regions of lobuloalveolar hyperplasia at the periphery of the gland

increased mammary adenocarcinoma incidence ( J:54215 )

• both sexes develop lobuloalveolar adenocarcinomas

mammary gland hyperplasia ( J:54215 )

• virgin females display underdeveloped glands at 10 weeks of age with a hyperplastic rudimentary ductal network that lacks terminal end buds

• unlike in transgenic mice wild-type for Esr1, hyperplasia does not progress with age in virgin females

• males display epithelial hyperplasia that does not extend into the inguinal fat pad similar to what is seen in females

integument

abnormal mammary gland development ( J:54215 )

• virgin females display underdeveloped glands at 10 weeks of age with a hyperplastic rudimentary ductal network that lacks terminal end buds

mammary gland duct hyperplasia ( J:54215 )

• in the interior of the gland in virgin females

mammary gland alveolar hyperplasia ( J:54215 )

• in virgin females, regions of lobuloalveolar hyperplasia at the periphery of the gland

increased mammary adenocarcinoma incidence ( J:54215 )

• both sexes develop lobuloalveolar adenocarcinomas

mammary gland hyperplasia ( J:54215 )

• virgin females display underdeveloped glands at 10 weeks of age with a hyperplastic rudimentary ductal network that lacks terminal end buds

• unlike in transgenic mice wild-type for Esr1, hyperplasia does not progress with age in virgin females

• males display epithelial hyperplasia that does not extend into the inguinal fat pad similar to what is seen in females

Allelic Composition	Id2^tm1Yyk/Id2^tm1Yyk Tg(Wnt1)1Hev/0
Genetic Background	involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB * SJL

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Id2^tm1Yyk mutation (0 available); any Id2 mutation (21 available)
Tg(Wnt1)1Hev mutation (2 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

endocrine/exocrine glands

abnormal branching of the mammary ductal tree ( J:96305 )

• mammary glands of virgin females have excessive ductal side branching resembling that of pregnant wild-type mice

increased mammary gland tumor incidence ( J:96305 )

• develop mammary tumors at a similar rate to that seen in single hemizygous Tg(Wnt1)1Hev mice

mammary gland hyperplasia ( J:96305 )

• mammary glands of virgin females have extensive, dense hyperplasia

neoplasm

increased mammary gland tumor incidence ( J:96305 )

• develop mammary tumors at a similar rate to that seen in single hemizygous Tg(Wnt1)1Hev mice

integument

abnormal branching of the mammary ductal tree ( J:96305 )

• mammary glands of virgin females have excessive ductal side branching resembling that of pregnant wild-type mice

increased mammary gland tumor incidence ( J:96305 )

• develop mammary tumors at a similar rate to that seen in single hemizygous Tg(Wnt1)1Hev mice

mammary gland hyperplasia ( J:96305 )

• mammary glands of virgin females have extensive, dense hyperplasia

Allelic Composition	Id2^tm1Yyk/Id2⁺ Tg(Wnt1)1Hev/0
Genetic Background	involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB * SJL

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Id2^tm1Yyk mutation (0 available); any Id2 mutation (21 available)
Tg(Wnt1)1Hev mutation (2 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

endocrine/exocrine glands

abnormal branching of the mammary ductal tree ( J:96305 )

• mammary glands of virgin females have excessive ductal side branching resembling that of pregnant wild-type mice

increased mammary gland tumor incidence ( J:96305 )

• develop mammary tumors at a similar rate to that seen in single Tg(Wnt1)1Hev mice

mammary gland hyperplasia ( J:96305 )

• mammary glands of virgin females have extensive, dense hyperplasia

neoplasm

increased mammary gland tumor incidence ( J:96305 )

• develop mammary tumors at a similar rate to that seen in single Tg(Wnt1)1Hev mice

integument

abnormal branching of the mammary ductal tree ( J:96305 )

• mammary glands of virgin females have excessive ductal side branching resembling that of pregnant wild-type mice

increased mammary gland tumor incidence ( J:96305 )

• develop mammary tumors at a similar rate to that seen in single Tg(Wnt1)1Hev mice

mammary gland hyperplasia ( J:96305 )

• mammary glands of virgin females have extensive, dense hyperplasia

Allelic Composition	Pten^tm1Rps/Pten⁺ Tg(Wnt1)1Hev/0
Genetic Background	involves: 129S1/Sv * C57BL/6 * FVB/N * SJL

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pten^tm1Rps mutation (1 available); any Pten mutation (88 available)
Tg(Wnt1)1Hev mutation (2 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased mammary gland ductal carcinoma incidence ( J:67497 )

• 50% of females develop mammary ductal carcinoma by 3.5 months of age, earlier than single Tg(Wnt1)1Hev hemizygotes, and all females show tumors by 5 months of age

• 2 of 22 tumors in males are mammary in origin

increased metastatic potential ( J:67497 )

• mutants occasionally show pulmonary metastasis

increased adenocarcinoma incidence ( J:67497 )

• tumors are adenocarcinomas with cribiform, cystic and focal papillary growth patterns

• 50% of males develop tumors by 5.5 months and all males develop tumors within 10 months

• 50% of females develop tumors by 3.5 months of age and all females have tumors within 5 months of age

• 6 of 22 tumors in males are bilateral or unilateral muzzle tumors of epithelial origin

• 7 or 11 tumors show loss of Pten heterozygosity

• most mutants (38 of 49) develop only one palpable tumor

increased salivary adenocarcinoma incidence ( J:67497 )

• 14 of 22 tumors in males arise in the salivary tissue

increased mammary adenocarcinoma incidence ( J:67497 )

endocrine/exocrine glands

increased salivary adenocarcinoma incidence ( J:67497 )

• 14 of 22 tumors in males arise in the salivary tissue

increased mammary adenocarcinoma incidence ( J:67497 )

increased mammary gland ductal carcinoma incidence ( J:67497 )

• 50% of females develop mammary ductal carcinoma by 3.5 months of age, earlier than single Tg(Wnt1)1Hev hemizygotes, and all females show tumors by 5 months of age

• 2 of 22 tumors in males are mammary in origin

integument

increased mammary adenocarcinoma incidence ( J:67497 )

increased mammary gland ductal carcinoma incidence ( J:67497 )

• 50% of females develop mammary ductal carcinoma by 3.5 months of age, earlier than single Tg(Wnt1)1Hev hemizygotes, and all females show tumors by 5 months of age

• 2 of 22 tumors in males are mammary in origin

digestive/alimentary system

increased salivary adenocarcinoma incidence ( J:67497 )

• 14 of 22 tumors in males arise in the salivary tissue

craniofacial

increased salivary adenocarcinoma incidence ( J:67497 )

• 14 of 22 tumors in males arise in the salivary tissue

growth/size/body

increased salivary adenocarcinoma incidence ( J:67497 )

• 14 of 22 tumors in males arise in the salivary tissue

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
breast cancer		DOID:1612	OMIM:114480	J:67497

Allelic Composition	Sdc1^tm1Cma/Sdc1⁺ Tg(Wnt1)1Hev/0
Genetic Background	involves: 129S4/SvJae * C57BL/6 * SJL

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Sdc1^tm1Cma mutation (0 available); any Sdc1 mutation (23 available)
Tg(Wnt1)1Hev mutation (2 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

decreased tumor incidence ( J:63122 )

• 30% of hemizygous females expressing the transgene in a Sdc1^tm1Cma heterozygous null background develop mammary tumors (median time: ~25 weeks) versus 34% of hemizygous females in a Sdc1 wild-type background (median time: ~21 weeks)

• these Wnt1-induced tumors are predominantly alveolar adenocarcinomas

Allelic Composition	Sdc1^tm1Cma/Sdc1^tm1Cma Tg(Wnt1)1Hev/0
Genetic Background	involves: 129S4/SvJae * C57BL/6 * SJL

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Sdc1^tm1Cma mutation (0 available); any Sdc1 mutation (23 available)
Tg(Wnt1)1Hev mutation (2 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

decreased tumor incidence ( J:63122 )

• only 3% of hemizygous females expressing the transgene in a Sdc1^tm1Cma null background develop mammary tumors (median time: ~36 weeks) versus 34% of hemizygous females in a Sdc1 wild-type background (median time: ~21 weeks)

• these Wnt1-induced tumors are predominantly alveolar adenocarcinomas

endocrine/exocrine glands

mammary gland hyperplasia ( J:63122 )

• hemizygous females expressing the transgene in a Sdc1^tm1Cma null background exhibit a ~70% inhibition of Wnt1-induced mammary gland hyperplasia relative to hemizygous females of a Sdc1 wild-type background

integument

mammary gland hyperplasia ( J:63122 )

Allelic Composition	Muc1^tm1Gend/Muc1^tm1Gend Tg(Wnt1)1Hev/?
Genetic Background	involves: FVB

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Muc1^tm1Gend mutation (1 available); any Muc1 mutation (39 available)
Tg(Wnt1)1Hev mutation (2 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

decreased tumor growth/size ( J:82470 )

• onset of mammary tumors was considerably delayed

• tumors were P-type

Allelic Composition	Chek1^tm1Sje/Chek1⁺ Tg(Wnt1)1Hev/0
Genetic Background	Not Specified

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Chek1^tm1Sje mutation (0 available); any Chek1 mutation (41 available)
Tg(Wnt1)1Hev mutation (2 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased mammary adenocarcinoma incidence ( J:62919 )

• earlier onset of mammary tumors (168 days versus 219 days of age) than in mice carrying only the transgene

• no differences in gross pathology, histopathology, or growth rates of these tumors compared to those in mice carrying only the transgene and not the Chek1 mutation

integument

increased mammary adenocarcinoma incidence ( J:62919 )

• earlier onset of mammary tumors (168 days versus 219 days of age) than in mice carrying only the transgene

• no differences in gross pathology, histopathology, or growth rates of these tumors compared to those in mice carrying only the transgene and not the Chek1 mutation

endocrine/exocrine glands

increased mammary adenocarcinoma incidence ( J:62919 )

• earlier onset of mammary tumors (168 days versus 219 days of age) than in mice carrying only the transgene

• no differences in gross pathology, histopathology, or growth rates of these tumors compared to those in mice carrying only the transgene and not the Chek1 mutation

Allelic Composition	Tg(Wnt1)1Hev/0
Genetic Background	either: FVB/N or (involves: C57BL/6 * SJL)

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Wnt1)1Hev mutation (2 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

endocrine/exocrine glands

abnormal mammary gland morphology ( J:28473 )

• mammary glands in virgin females resemble hormonally-stimulated glands from pregnant mice

abnormal branching of the mammary ductal tree ( J:28473 )

• hemizygous transgenic females show a marked increase in the number of terminal branches

abnormal mammary gland lobule morphology ( J:28473 )

• hemizygous transgenic females display diffuse lobular hyperplasia

mammary gland alveolar hyperplasia ( J:28473 )

integument

abnormal mammary gland morphology ( J:28473 )

• mammary glands in virgin females resemble hormonally-stimulated glands from pregnant mice

abnormal branching of the mammary ductal tree ( J:28473 )

• hemizygous transgenic females show a marked increase in the number of terminal branches

abnormal mammary gland lobule morphology ( J:28473 )

• hemizygous transgenic females display diffuse lobular hyperplasia

mammary gland alveolar hyperplasia ( J:28473 )

Allelic Composition	Tg(Wnt1)1Hev/0
Genetic Background	involves: 129P2/OlaHsd * C57BL/6 * SJL

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Wnt1)1Hev mutation (2 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased mammary adenocarcinoma incidence ( J:54215 )

• both sexes develop lobuloalveolar adenocarcinomas

• tumor development or progression is not affected by pregnancies or ovariectomy

endocrine/exocrine glands

mammary gland duct hyperplasia ( J:54215 )

• in virgin females

mammary gland alveolar hyperplasia ( J:54215 )

• lobuloalveolar hyperplasia in virgin females

increased mammary adenocarcinoma incidence ( J:54215 )

• both sexes develop lobuloalveolar adenocarcinomas

• tumor development or progression is not affected by pregnancies or ovariectomy

mammary gland hyperplasia ( J:54215 )

• at 10 weeks of age in virgin females

• at 6 months of age in virgin females, hyperplastic epithelium fills the entire inguinal fat pad

• males display epithelial hyperplasia that does not extend into the inguinal fat pad

integument

mammary gland duct hyperplasia ( J:54215 )

• in virgin females

mammary gland alveolar hyperplasia ( J:54215 )

• lobuloalveolar hyperplasia in virgin females

increased mammary adenocarcinoma incidence ( J:54215 )

• both sexes develop lobuloalveolar adenocarcinomas

• tumor development or progression is not affected by pregnancies or ovariectomy

mammary gland hyperplasia ( J:54215 )

• at 10 weeks of age in virgin females

• at 6 months of age in virgin females, hyperplastic epithelium fills the entire inguinal fat pad

• males display epithelial hyperplasia that does not extend into the inguinal fat pad

Allelic Composition	Tg(Wnt1)1Hev/0
Genetic Background	involves: C57BL/6 * FVB * SJL

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Wnt1)1Hev mutation (2 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

endocrine/exocrine glands

abnormal branching of the mammary ductal tree ( J:96305 )

• mammary glands of virgin females have excessive ductal side branching resembling that of pregnant wild-type mice

increased mammary gland tumor incidence ( J:96305 )

• develop mammary tumors

mammary gland hyperplasia ( J:96305 )

• mammary glands of virgin females have extensive, dense hyperplasia

neoplasm

increased mammary gland tumor incidence ( J:96305 )

• develop mammary tumors

integument

abnormal branching of the mammary ductal tree ( J:96305 )

• mammary glands of virgin females have excessive ductal side branching resembling that of pregnant wild-type mice

increased mammary gland tumor incidence ( J:96305 )

• develop mammary tumors

mammary gland hyperplasia ( J:96305 )

• mammary glands of virgin females have extensive, dense hyperplasia

Allelic Composition	Tg(Wnt1)1Hev/0
Genetic Background	involves: C57BL/6 * SJL

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Wnt1)1Hev mutation (2 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased mammary adenocarcinoma incidence ( J:61009 )

• at 18 weeks

endocrine/exocrine glands

mammary gland duct hyperplasia ( J:61009 )

• at 18 weeks

increased mammary adenocarcinoma incidence ( J:61009 )

• at 18 weeks

integument

mammary gland duct hyperplasia ( J:61009 )

• at 18 weeks

increased mammary adenocarcinoma incidence ( J:61009 )

• at 18 weeks

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
breast cancer		DOID:1612	OMIM:114480	J:61009

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 12/10/2024 MGI 6.24